Pharma exports from Sweden have increased sharply during the first half of this year, figures show.
They amounted to approximately 70 billion Swedish kronor ($6.5 billion), compared to 50 billion kronor in the first half of 2021, according to Statistics Norway (SCB), the neighboring country’s bureau for stats.
This is an increase of 38% in economic value. The rise in volume was 34%, which is the highest increase among all export goods.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze